(BMO) Bank of Montreal - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0636711016

BMO: Banking, Insurance, Investments, Credit, Lending, Mortgages

Bank of Montreal, or BMO, stands as one of Canadas most enduring financial institutions, with roots tracing back to 1817. This storied bank operates primarily across North America, dividing its operations into four key segments: Canadian Personal and Commercial Banking, U.S. Personal and Commercial Banking, BMO Wealth Management, and BMO Capital Markets. This diversified approach allows BMO to cater to a broad spectrum of financial needs, from individual consumers to large corporations.

In the realm of personal banking, BMO offers an array of services including deposits, mortgages, consumer credit, and investment advice, all designed to meet the everyday financial needs of its customers. On the commercial side, BMO provides comprehensive solutions such as financing options, treasury services, and risk management products, essential for businesses aiming to manage their financial operations effectively.

BMO Wealth Management extends its reach to institutional, retail, and high net worth clients, offering investment management and wealth advisory services. This segment underscores BMOs commitment to serving a diverse clientele, ensuring that each groups unique financial goals are addressed with tailored strategies. Additionally, BMO Capital Markets excels in corporate and investment banking, offering services in mergers and acquisitions, debt and equity financing, and risk management, positioning BMO as a pivotal player in the capital markets landscape.

For investors and fund managers, BMO presents a compelling case with a market capitalization exceeding 103 billion CAD, indicating significant stability and market presence. The price-to-earnings ratio of nearly 15, coupled with a forward P/E of 12.95, suggests a moderate valuation, while the price-to-book ratio of 1.27 highlights reasonable pricing relative to book value. These metrics are crucial for assessing the stocks attractiveness in the current market environment

Additional Sources for BMO Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

BMO Stock Overview

Market Cap in USD 73,266m
Sector Financial Services
Industry Banks - Diversified
GiC Sub-Industry Diversified Banks
IPO / Inception

BMO Stock Ratings

Growth 5y 59.9%
Fundamental 9.56%
Dividend 64.8%
Rel. Strength Industry -9.44
Analysts -
Fair Price Momentum 146.76 CAD
Fair Price DCF 582.88 CAD

BMO Dividends

Dividend Yield 12m 4.65%
Yield on Cost 5y 8.02%
Annual Growth 5y 4.00%
Payout Consistency 75.1%

BMO Growth Ratios

Growth Correlation 3m 77.2%
Growth Correlation 12m 58.6%
Growth Correlation 5y 71.4%
CAGR 5y 13.09%
CAGR/Max DD 5y 0.30
Sharpe Ratio 12m 0.70
Alpha 3.51
Beta 0.60
Volatility 15.69%
Current Volume 2852.6k
Average Volume 20d 3771.4k
What is the price of BMO stocks?
As of February 22, 2025, the stock is trading at CAD 142.96 with a total of 2,852,584 shares traded.
Over the past week, the price has changed by -0.17%, over one month by +0.52%, over three months by +9.30% and over the past year by +17.77%.
Is Bank of Montreal a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Bank of Montreal is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.56 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BMO as of February 2025 is 146.76. This means that BMO is currently overvalued and has a potential downside of 2.66%.
Is BMO a buy, sell or hold?
Bank of Montreal has no consensus analysts rating.
What are the forecast for BMO stock price target?
According to ValueRays Forecast Model, BMO Bank of Montreal will be worth about 162.4 in February 2026. The stock is currently trading at 142.96. This means that the stock has a potential upside of +13.6%.
Issuer Forecast Upside
Wallstreet Target Price 146.9 2.7%
Analysts Target Price - -
ValueRay Target Price 162.4 13.6%